PATH | VRL
Menu

Vaccine-Preventable Haemophilus influenzae type B Disease Burden and Cost-Effectiveness of Infant Vaccination in Indonesia

This article, published in the Pediatric Infectious Disease Journal, estimates total vaccine-preventable disease burden and the cost-effectiveness of Hib conjugate vaccine in Indonesia. The study concludes that routine infant Hib vaccination would prevent a large burden of pediatric illness and death in Indonesia. Even without external funding support, Hib vaccine will be a highly cost-effective intervention in either a monovalent or pentavalent presentation based on commonly used benchmarks. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Gessner BD, Sedyaningsih ER, Griffiths UK, et al.

Published: 2008

» Visit web page (English)

(Located at www.ncbi.nlm.nih.gov)

Citation: Gessner BD, Sedyaningsih ER, Griffiths UK, et al. Vaccine-preventable Haemophilus influenzae type B Disease Burden and Cost-effectiveness of Infant Vaccination in Indonesia. Pediatric Infectious Disease Journal. 2008;27(5):438-443.

Resource types: Peer-reviewed journal

Diseases/vaccines: Haemophilus influenzae type b (Hib)

Topics: Immunization financing, Disease burden and surveillance, Disease/vaccine specific information

Regions: Asia